Podcasts about revealing retina

CME credits: 0.25 Valid until: 30-10-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/viewpoints-on-managing-dr-addressing-moderate-to-severe-npdr/10905/ Even though the prevalence of diabetes continues to rise globally, the good news is that there are emerging treatment options for diabetic eye diseases like nonproliferative diabetic retinopathy. Join Dr. David Brown and Dr. Rishi Singh as they review the recent evidence behind one of these options: anti-VEGF inhibitors. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 30-10-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/seeing-eye-to-eye-case-series-on-treatment-strategies-for-diabetic-retinopathy-pdr-dme/10906/ As the management of diabetic retinopathy and diabetic macular edema continues to evolve, those devoted to retinal care continue to learn about what can be done now to better manage and individualize treatment for patients with these conditions. This discussion between Dr. Sharon Solomon and Dr. Charles Wykoff will review the current and emerging treatment paradigms for managing diabetic retinopathy and diabetic macular edema and considerations for applying them into clinical practice. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another key aspect that can unfortunately be easy to overlook is care collaboration. Featuring Dr. Janine Clayton, Dr. A. Paul Chous, and Dr. Anne Peters, this discussion will focus on how providers can work together to optimize patients’ eye health and minimize their risk of vision loss from diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD Guest: Charles Wykoff, MD, PhD Even though diabetic retinopathy is the leading cause of blindness among U.S. adults, a substantial number of patients with diabetes are not receiving routine eye exams and are at risk of vision loss. Making matters worse is the fact that many patients with diabetes remain unaware that this disease can affect their vision. That’s why this discussion with a panel of expert faculty will examine what it means to be proactive in promoting vision screening and minimizing the risk for vision loss with appropriate early treatment in these patients. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another key aspect that can unfortunately be easy to overlook is care collaboration. Featuring Dr. Janine Clayton, Dr. A. Paul Chous, and Dr. Anne Peters, this discussion will focus on how providers can work together to optimize patients’ eye health and minimize their risk of vision loss from diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 31-12-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/diabetic-retinopathy-understanding-the-impact-on-patient-lives-and-the-need-for-timely-diagnosis/10898/ Even though diabetic retinopathy is the leading cause of blindness among U.S. adults, a substantial number of patients with diabetes are not receiving routine eye exams and are at risk of vision loss. Making matters worse is the fact that many patients with diabetes remain unaware that this disease can affect their vision. That’s why this discussion with a panel of expert faculty will examine what it means to be proactive in promoting vision screening and minimizing the risk for vision loss with appropriate early treatment in these patients. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 31-12-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/advances-npdr-retina-specialist-perspective/10899/ The treatment of nonproliferative diabetic retinopathy (NPDR) in the presence of diabetic macular edema is well established, but what about those patients with severe NPDR who do not have diabetic macular edema? To find out, Dr. Diana Do sits down with Dr. Peter Kaiser and Dr. Charles Wykoff, who review recent clinical trial data from the PANORAMA study and its treatment implications. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 31-12-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/in-plain-sight-evaluating-all-patients-with-diabetes-for-diabetic-retinopathy/10900/ When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another key aspect that can unfortunately be easy to overlook is care collaboration. Featuring Dr. Janine Clayton, Dr. A. Paul Chous, and Dr. Anne Peters, this discussion will focus on how providers can work together to optimize patients’ eye health and minimize their risk of vision loss from diabetic retinopathy and diabetic macular edema. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 31-12-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/viewpoints-on-managing-dr-addressing-moderate-to-severe-npdr/10905/ Even though the prevalence of diabetes continues to rise globally, the good news is that there are emerging treatment options for diabetic eye diseases like nonproliferative diabetic retinopathy. Join Dr. David Brown and Dr. Rishi Singh as they review the recent evidence behind one of these options: anti-VEGF inhibitors. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 31-12-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/seeing-eye-to-eye-case-series-on-treatment-strategies-for-diabetic-retinopathy-pdr-dme/10906/ As the management of diabetic retinopathy and diabetic macular edema continues to evolve, those devoted to retinal care continue to learn about what can be done now to better manage and individualize treatment for patients with these conditions. This discussion between Dr. Sharon Solomon and Dr. Charles Wykoff will review the current and emerging treatment paradigms for managing diabetic retinopathy and diabetic macular edema and considerations for applying them into clinical practice. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 15-09-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/advances-npdr-retina-specialist-perspective/10899/ The treatment of nonproliferative diabetic retinopathy (NPDR) in the presence of diabetic macular edema is well established, but what about those patients with severe NPDR who do not have diabetic macular edema? To find out, Dr. Diana Do sits down with Dr. Peter Kaiser and Dr. Charles Wykoff, who review recent clinical trial data from the PANORAMA study and its treatment implications. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 15-09-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/preventing-vision-loss-in-moderate-to-severe-npdr-applying-advancesments-to-practice/10905/ Even though the prevalence of diabetes continues to rise globally, the good news is that there are emerging treatment options for diabetic eye diseases like nonproliferative diabetic retinopathy. Join Dr. David Brown and Dr. Rishi Singh as they review the recent evidence behind one of these options: anti-VEGF inhibitors. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

CME credits: 0.25 Valid until: 15-09-2020 Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/saving-sight-through-action-right-therapy-at-the-right-time-for-pdr-dme/10906/ As the management of diabetic retinopathy and diabetic macular edema continues to evolve, those devoted to retinal care continue to learn about what can be done now to better manage and individualize treatment for patients with these conditions. This discussion between Dr. Sharon Solomon and Dr. Charles Wykoff will review the current and emerging treatment paradigms for managing diabetic retinopathy and diabetic macular edema and considerations for applying them into clinical practice. Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.

Host: Roy Levit, MD Guest: Saad Shaikh, MD Although floaters in one's vision are common, this symptom can be a key indicator of a retinal tear or detachment. What is the incidence of retinal detachment in the U.S., and when should a primary care physician suspect this condition? Dr. Saad Shaikh, associate professor and member of the teaching faculty at the University of Central Florida College of Medicine in Orlando, and assistant professor at the University of South Florida, College of Medicine and at the Florida State College of Medicine, discusses the development of retinal detachments, risk factors, and the techniques used to correct the condition. Dr. Roy Levit hosts.

Host: Roy Levit, MD Guest: Alan Ruby, MD The eyes can yield clues to vascular issues elsewhere in the body. How can the two forms of diabetic retinopathy, which are non-proliferative and proliferative, affect vision, and how might retinopathy be associated with somatic effects resulting from diabetes? Dr. Alan Ruby, opthamologist and clinical assistant professor of biomedical sciences at the Eye Research Institute at Oakland University, in Rochester, Michigan, discusses the correlation between diabetic retinopathy and complications throughout the body. Can tight control of diabetes affect the progression or regression of retinopathy? What can physicians caring for patients with diabetes do to identify vision changes early on, and potentially reduce the risk of later complications? Dr. Roy Levit hosts.

Host: Roy Levit, MD Guest: Alan Ruby, MD The standard treatment for proliferative and non-proliferative diabetic retinopathy is laser photocoagulation, but novel methods, including injectable steroids or anti-vascular endothelial growth factor, are also showing promise. What tests can help opthamologists determine the area of leakage in the eye that needs treatment? How soon after surgery will patients see a change in their vision? Dr. Alan Ruby, opthamologist and clinical assistant professor of biomedical sciences at the Eye Research Institute at Oakland University, in Rochester, Michigan, discusses ways to maximize the overall visual outcome for patients with diabetic retinopathy. How can diabetic retinopathy be prevented? Dr. Roy Levit hosts.

Host: Roy Levit, MD Guest: Albert O. Edwards, MD, PhD Geneticists think of age-related macular degeneration (AMD) as a complex trait in which multiple environmental and epidemiological risks combine to cause the disease. Dr. Albert O. Edwards is a consultant and an opthalmologist at the Mayo Clinic in Minnesota, discusses with host Dr. Levitt the genetic approach for identifying biological pathways involved in the disease, and explains how to interpret the genetic studies. Dr. Edwards also outlines the importance of lifestyle choices, such as exercise, low-fat diet and other heart-healthy behaviors, to reduce their risk of developing AMD regardless of one's knowledge of the genetic risk. Tune in to hear Dr. Edwards clarify the relationship between genetics and AMD.

Host: Roy Levit, MD Guest: Allen Ho, MD What are macular holes and macular pucker, and how do we treat these conditions? Host Dr. Roy Levit welcomes Dr. Allen Ho, professor of ophthalmology and an attending surgeon in the Retina Service at the Wills Eye Institute in Philadelphia, to discuss back-of-the-eye vitrectomy for the treatment of macular hole and macular pucker. Before this surgical procedure, we had no cure for these diagnoses.

Host: Roy Levit, MD Guest: Mark Humayun, MD Microelectronic implants are restoring vision to the blind.Dr. Mark Humayun discusses with host Dr. Roy Levit the workings of the artificial retina and explains the surgical procedure to implant the device in the eye. The first generation of the implant only has 16 pixels while the second generation has 62 pixels. Dr. Humayun explains how the subjects who have the implant can initially see spots of light, but that the brain over time can fill in the details and many patients are able to see objects, motion and color. At this time, the implants are available only as a part of the clinical trial to subjects who are completely blind as a result of retinitis pigmentosa.

Host: Roy Levit, MD Dr. Richard Rosen, surgeon director for the department of ophthalmology and director of ophthalmic research in the Advanced Imaging Center at New York Eye and Ear Infirmary, joins host Dr. Roy Levit to discuss technologies and methods to examine the retina.

Host: Roy Levit, MD Guest: Cliff Ratner, MD Dr. Roy Levit welcomes Dr. Cliff Ratner to the Revealing Retina. Dr. Ratner did his residency at Harkness Eye Institute and a 2 Year Retina Fellowship at Wilmer Institute at Johns Hopkins. He has been in private practice for 25 years and is the founder of The Retina Practice of White Plains in New York. With his vast experience and expertise, he will talk about how much has changed and is currently changing in the treatment for Wet Macular Degeneration.

Host: Roy Levit, MD Guest: Paul Tornambe, MD Dr. Roy Levit welcomes Dr. Paul Tornambe to The Revealing Retina. Dr. Tornambe is in private practice in the San Diego/La Jolla area, and has written over a dozen peer reviewed papers on vitreo retinal disease. He lectures worldwide and is a Journal Referee for the AJO, Archives of Ophthalmology, Retina, British Journal of Ophthalmology, and the German Journal of Ophthalmology. He is a past president of the American Society of Retina Specialists. Dr. Tornambe will discuss the fact that because most residents eventually become board certified, the overall certification rate for the American Board of Ophthalmology (ABO) is not a discriminating educational outcome measure. He will talk about resident performance from program match to certification.

Host: Roy Levit, MD Guest: David Williams, MD Dr. Roy Levit welcomes Dr. David F. Williams to The Revealing Retina. Dr. Williams is a Vitreoretinal Specialist practicing in Minneapolis. He is currently Vice President as well as Program Chairman of the ASRS--American Society of Retina Specialists. Dr. Williams will discuss Wet Age-Related Macular Degeneration, also known as Neovascular AMD or Exudative AMD. He will highlight the symptoms and how to make a definitive diagnosis as well as the importance of the location of neovascular lesions as a vital factor affecting the progression of the disease and the risk of vision loss.

Host: Roy Levit, MD Guest: Michael Newton, MD Dr. Roy Levit is joined by Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. He has a Masters Degree in Bioethics, Science and Society from CUNY in New York City. Dr. Newton is the author of the book, "Without Your Consent, The Hijacking of American Health Care". They will discuss how the outside influences on healthcare has led to a loss of trust between doctor and patient.

Host: Roy Levit, MD Guest: Michael Newton, MD Dr. Roy Levit welcomes Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. They will dicuss Dr. Newton's book, "Without Your Consent, The Hijacking of American Health Care". They will cover all of the outside influences from managed care to hospitals to government that are influencing the way MD's practice medicine today.

Host: Roy Levit, MD Guest: Jerald Bovino, MD Dr. Roy Levit welcomes Dr. Jerald Bovino to the Revealing Retina. Dr. Bovino is a retired retinal surgeon who is well published in the area of physician retirement. Physician retirement issues will be explored and advice given. Some examples in the retinal field will be cited.

Guest: Nicholas Zakov, MD Dr. Roy Levit welcomes Dr. Nicholas Zakov to the Revealing Retina. Dr. Zakov is a partner in Retina Associates of Cleveland, the largest Vitreoretinal group in Ohio and a clinical professor of Ophthalmology at University Hospitals Case Medical Center in Cleveland. They will be discussing the warning signs of flashes and floaters as well as common vs. uncommon causes and several treatments.

Host: Roy Levit, MD Guest: Julia Haller, MD Dr. Roy Levit welcomes Dr. Julia Haller to The Revealing Retina. Dr. Haller is President of the American Society of Retina Specialists and Chairman, Wills Eye Hospital, Philadelphia. Tune in to hear everything new in the treatment of macular degeneration.

Host: Roy Levit, MD Guest: Julia Haller, MD Dr. Roy Levit welcomes Dr. Julia Haller to The Revealing Retina. Dr. Haller is President of the American Society of Retina Specialists and Chairman, Wills Eye Hospital, Philadelphia. They will discuss the different types of macular degeneration, the demographics involved and who should be treating it.

Guest: Suber Huang, MD Tune in to hear Dr. Roy Levit, host and president of the American Retina Fundation, as he welcomes Dr. Suber Huang, Director of Vitreoretinal Diseases and Surgery at University Hospitals of Cleveland, and Medical Director and Treasurer for University Ophthalmologists, Inc. Dr. Huang will discuss the intricacies of Diabetic Retinopathy.

Guest: Suber Huang, MD Tune in to hear the first in a monthly series entitled, "The Revealing Retina". Dr. Roy Levit, host and president of the American Retina Fundation, welcomes Dr. Suber Huang, Director of Vitreoretinal Diseases and Surgery at University Hospitals of Cleveland, and Medical Director and Treasurer for University Ophthalmologists, Inc. to discuss Diabetic Retinopathy, it's cause and effects. Listeners will gain information on how to understand and identify visual changes in their diabetic patients.